Publicación:
Cáncer de piel: Una realidad cotidianamente ignorada.

Vista sencilla de ítem
dc.contributor.authorIregui Piñeros, María Lucíaspa
dc.contributor.authorRonderos Osorio, Jaimespa
dc.date.accessioned2017-09-21T00:00:00Z
dc.date.accessioned2025-08-05T14:41:05Z
dc.date.available2017-09-21T00:00:00Z
dc.date.available2025-08-05T14:41:05Z
dc.date.issued2017-09-21
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.26752/ccomunitaria.v24.n137.212
dc.identifier.eissn2539-0503
dc.identifier.issn0123-1588
dc.identifier.urihttps://repositorio.juanncorpas.edu.co/handle/001/609
dc.identifier.urlhttps://doi.org/10.26752/ccomunitaria.v24.n137.212
dc.language.isospaspa
dc.publisherFundación Universitaria Juan N. Corpasspa
dc.relation.bitstreamhttps://revistas.juanncorpas.edu.co/index.php/cartacomunitaria/article/download/212/197
dc.relation.citationeditionNúm. 137 , Año 2016 : Carta Comunitaria N° 137spa
dc.relation.citationendpage78
dc.relation.citationissue137spa
dc.relation.citationstartpage48
dc.relation.citationvolume24spa
dc.relation.ispartofjournalCarta Comunitariaspa
dc.relation.referencesCancer incidence in five continents. IARC Sci Publ. 2008; IX(160):1-837.spa
dc.relation.referencesDiepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002; 146 Suppl 61:1-6.spa
dc.relation.referencesSánchez G, Nova J, De la Hoz F, Castañeda C. Incidencia de cáncer de piel en Colombia. Años 2003-2007. Piel. 2011; 26 (4):171-7.spa
dc.relation.referencesGaravís JL. Precáncer y cáncer cutáneo en AP. En: Semergen 2003; 29(7); 360-367. [Internet] 2003 [citado 11 septiembre 2014]. Disponible en: http://www.sciencedirect.com/science.spa
dc.relation.referencesFundación Universitaria de Ciencias de la Salud, Instituto Nacional de Cancerología, Centro Dermatológico Federico Lleras Acosta y Asociación Colombiana de Dermatología y Cirugía Dermatológica -ASOCOLDERMA. Guía de práctica clínica con evaluación económica para la prevención, diagnóstico, tratamiento y seguimiento del cáncer de piel no melanoma: Guía para pacientes, padres y cuidadores.spa
dc.relation.referencesInstituto Nacional de Cancerología ESE, Ministerio de Salud y Protección Social. Anuario Estadístico 2011. Bogotá́: Milenio Editores. 2014; 9:28.spa
dc.relation.referencesPardo C, Cendales R. Incidencia, mortalidad y prevalencia de cáncer en Colombia, 2007-2011. Primera edición. Bogotá́. D.C. Instituto Nacional de Cancerología. 2015; 1:148.spa
dc.relation.referencesInternational Agency Research on Cancer. CI5 I-X Cancer incidence in five continents volume X (2003-2007). [on line] 2015 [citado 27 febrero 2015] disponible en: http://ci5.iarc.fr/CI5I-Xspa
dc.relation.referencesInternational Agency for Research on Cancer–OMS. GLOBOCAN 2012 Estimated cancer incidence mortality and prevalence Worldwide in 2012. World. Population Facts Sheets. [On line] 2012 [cited 10 September 2014] availablein:http://globocan.iarc.fr/Pages/fact_sheets_population.aspxspa
dc.relation.referencesSurveillance, Epidemiology and End Results Program (SEER). National Institutes of Health. SEER stat fact sheets: melanoma of skin. [On line] 2011 [citado 10 septiembre 2014]. Disponible en: http://www.seer.cancer.gov/ statfacts/html/melan.htmlspa
dc.relation.referencesMcKenzie RL, Aucamp PJ, Bais AF, Bjorn LO, Ilyas M. Changes in biologically- active ultraviolet radiation reaching the Earth ́s surface. Photochemical y photobiological sciences. 2007; 6(3): 218-231. Pubmed PMID: 17344959. Citado por: Sánchez Guillermo. Cáncer de piel no melanoma: riesgos e itinerarios. Bogotá: Universidad Nacional de Colombia. 2013; p. 37.spa
dc.relation.referencesBulliard JL, Cox B, Elwood JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control. 1994; 5: 234–240. Citado por: S Wu, J Han, R.A Vleugels, R Puett, F Laden, DJ Hunter and Qureshi. Cumulative ultaviolet radiation flux in adulthood and risk of incident skin cancers in women. British Journal of Cancer [on line] 2014 March [cited 2014 Oct 30]; 110: 1855-1861. Available from: http://www. nature.com/bjc/journal/v110/n7/full/bjc201443a.html. p.1854.spa
dc.relation.referencesAlmahroos M, Kurban AK (2004). Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 3:29–35, quiz35-36. Citado por: S Wu, J Han, R.A Vleugels, R Puett, F Laden, DJ Hunter and Qureshi. Cumulative ultaviolet radiation flux in adulthood and risk of incident skin cancers in women. British Journal of Cancer [on line] 2014 March [cited 2014 Oct 30]; 110: 1855-1861. Available from:http://www.nature.com/bjc/journal/v110/n7/full/bjc201443a.html. p.1854.spa
dc.relation.referencesQureshi AA, Laden F, Colditz GA, Hunter DJ (2008). Geographic variation and risk of skin cancer in US women. Diferences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med [on line] 2008 [cited 2014 Oct 30]; 168: 501–507. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/1833229.spa
dc.relation.referencesSuzuki T, Ueda M, Ogata K, Horikoshi T, Munakata N, Ichihashi M. Doses of solar ultraviolet radiation correlate with skin cancer rates in Japan. Kobe J Med Sci. 1996; 42: 375–388. Citado por: S Wu, J Han, R.A Vleugels, R Puett, F Laden, DJ Hunter and Qureshi. Cumulative ultaviolet radiation flux in adulthood and risk of incident skin cancers in women. British Journal of Cancer [on line] 2014 March [cited 2014 Oct 30]; 110: 1855-1861. Available from: http://www. nature.com/bjc/journal/v110/n7/full/bjc201443a.html. p.1854spa
dc.relation.referencesLeiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer–the role of sunlight. Adv Exp Med Biol. 2008; 624: 89–103. Citado por: S Wu, J Han, R.A Vleugels, R Puett, F Laden, DJ Hunter and Qureshi. Cumulative ultaviolet radiation flux in adulthood and risk of incident skin cancers in women. British Journal of Cancer [on line] 2014 March [cited 2014 Oct 30]; 110: 1855-1861. Available from: http://www.nature.com/bjc/journal/v110/ n7/full/bjc201443a.html. p.1854.spa
dc.relation.referencesPozzobón F, Acosta A, Carreño A, Fierro E. Características del melanoma cutáneo primario en el Instituto Nacional de Cancerología 2006-2010. [en línea] En: Rev Col Cancerol. 2013; 17(3):111-118. [citado el 14 de enero de 2015] disponible en: http://zl.elsevier.es. p.114.spa
dc.relation.referencesDong C, Hemminki K. Int J Cancer. 2001; Jul 15; 93(2):155-61. Second primary neoplasm in 633.964 cancer patients in Sweden, 1958-1996. Citado por: Guianeya S, Lombardo K y Rodríguez R. Tumores múltiples análisis de 25 casos. En: Salud Militar. 2006; 28(1):73-80.spa
dc.relation.referencesFlohil SC, van der Leest RJ, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2013; 49(10):2365-75.spa
dc.relation.referencesVan der Leest RJ, Flohil SC, Arends LR, de Vries E, Nijsten T. El riesgo de malignidad cutánea posterior en pacientes con melanoma antes: una revisión sistemática y metanálisis. J Eur Acad Dermatol Venereol. 2014; diciembre 10.spa
dc.relation.referencesBath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;(1):CD003412.spa
dc.relation.referencesAcosta A, Ramírez A, Rueda X. Carcinoma escamocelular. En: Atlas Dermatología Oncológica. Instituto Nacional de Cancerología. CD multimedia. Bogotá́: 2006.spa
dc.relation.referencesPeñaranda E, Rolon M, Acosta AE, Rueda X. Concordancia entre biopsia incisional y pieza quirúrgica en los subtipos histológicos del carcinoma basocelular. Protocolos investigación I.N.C. 2001.spa
dc.relation.referencesGallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, Threlfall WJ, et al. Sunlight exposure, pigmentary factors and risk of non-melanocytic skin cancer. Basal cell carcinoma. Arch Derm. 1995; 131: 157-163.spa
dc.relation.referencesGuidelines Index Basal Celland Squamous Cell TOCStaging, MS, Clinical Practice Guidelines in Oncology – v.2.2005. National Comprehensive Cancer Network.spa
dc.relation.referencesSilverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J-Dermatol-Surg-Oncol. 1992; 18: 471-6.spa
dc.relation.referencesRubin A, Chen E, Ratner D. Currentconcepts Basalcellcarcinoma. N Engl J Med. 2005; 353: 2262-9.spa
dc.relation.referencesMiller SJ. Basal Cell Carcinoma -Risk Factors, in: Miller S, Maloney M et al. Cutaneos Oncology. England: Blackwell Science. 1998; 614-8.spa
dc.relation.referencesAcosta A, Rueda X. Indicaciones terapéuticas del carcinoma basocelular y escamocelular según sus factores de riesgo. En Coiffman P, et al. Cirugía plástica, reconstructiva y estética de cabeza y cuello. Tercera edición, Tomo 2. Amolca; 2007; 965-84.spa
dc.relation.referencesMikhail GR, Nims LP, Kelly AP Jr, Ditmars DM Jr, Eyler WR. Metastatic basal cell carcinoma. Review, pathogenesis and report of two cases. Arch Derm. 1977; 113:1261-1269.spa
dc.relation.referencesEpstein E. Fluorouracil paste treatment of the basal cell carcinoma. Arch Derm. 1985; 121: 207-213.spa
dc.relation.referencesGoette DK. Topical chemotherapy with 5-fluorouracil. A review. J Am Acad Dermatol.1981; 4: 633-49.spa
dc.relation.referencesBergstresser P, Halprin K. Multiple sequential skin cancer. The risk of skin cancer in patients with previous skin cancer. Arch Derm. 1975; 111: 995-6.spa
dc.relation.referencesEpstein E. Value of follow-up after treatment of basal cell carcinoma. Arch Derm. 1973; 106: 798-800.spa
dc.relation.referencesMiller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Making. 1994; 14(1):52-8.spa
dc.relation.referencesCriscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Airs Topical Tretinoin Chemoprevention Trial. Cancer. 2009; 115(11):2523-30.spa
dc.relation.referencesLansbury L, Leonardi J, Perkins W, Goodacre T, Tweed JA, Bath FJ. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev. 2010; (4):CD007869.spa
dc.relation.referencesNCCN. National Comprehensive Cancer Network. Basal Cell and Squamous Cell Skin Cancers. NCCN Guidelines. 2014; 2:1- 48. Disponible en: www.nccn.com.spa
dc.relation.referencesGupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012; 12:CD004415.spa
dc.relation.referencesLópez JM, Cebrián JL, Palacios E, Macarrón J, Pingarrón L, Demaría G et al. Carcinoma cutáneo de células de Merkel: Presentación de un caso y revisión de la literatura. Rev Esp Cirug Oral y Maxilofac [revista en la Internet]. 2008 Feb [citado 2015 Feb 26]; 30(1): 29-34. Disponible en:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130- 05582008000100004&lng=esspa
dc.relation.referencesGoessling W. Merkel cell carcinoma. J Clin Oncol 2002; 20:588-598. Citado por: López JM, Cebrián JL, Palacios E, Macarrón J, Pingarrón L, Demaría G et al. Carcinoma cutáneo de células de Merkel: Presentación de un caso y revisión de la literatura. Rev Esp Cirug Oral y Maxilofac [revista en la Internet]. 2008 Feb [citado 2015 Feb 26]; 30(1): 29-34. Disponible en:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130- 05582008000100004&lng=esspa
dc.relation.referencesBiblioteca Nacional de Medicina de EEUU. Sarkoma de Kaposi. [en línea] 2012 [citado 27 febrero 2015]. Disponible en: http://www.nlm.nih.gov/medlineplus/ spanish/ency/article/000661.htmspa
dc.relation.referencesChao AN, Shields CL, Krema H, Shields JA. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophtalmology [internet]. 2001 April [citado 2015 Feb 27] 108: 1877-1883. Disponible en: http://www.aaojournal.org/article/ S0161-6420%2801%2900719-9/pdfspa
dc.relation.referencesShields JA, Demirci H, Marr BP, Eagle RC Jr, Stefanyszyn M, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004. [Internet]. 2004 Jul [citado 2015 Feb 27]; 111: 2151-2157. Disponible en: http://www.sciencedirect.com/science/article/pii/S0161642004012928spa
dc.relation.referencesNi C, Searl S, Kuo PK. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin 1982; 22: 23-61. Iglesias I, Troyano J, Díaz D, Genol I. Citado por: Carcinoma de glándulas sebáceas: presentación de dos casos clínicos. Arch Soc Esp O almol [revista en la Internet]. 2008 Jul [citado 2015 Feb 27]; 83(7): 445-448. Disponible en: http://scielo.isciii.es/scielo. php?script=sci_arttext&pid=S0365-66912008000700011&lng=esspa
dc.relation.referencesMohr P et al. Staging of cutaneous melanoma. Annals of Onc. 20 (supplement 6): 14-21, 2009.spa
dc.relation.referencesShumate CR, Urist MM, Maddox WA. Melanoma recurrence surveillance. Patient or physician based? Ann Surg 221:566-9, 1995.spa
dc.relation.referencesWeiss, M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of Follow-up Tests for Detecting Recurrent Disease in Patients With Malignant Melanomas. JAMA 274:1703-1705, 1995.spa
dc.relation.referencesGarbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Evidence and interdisciplinary consense-based. German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 2007 Dec; 17(6):393-9.spa
dc.relation.referencesKatz KA, Jonasch E, Hodi FS, Soiffer R, Kwitkiwski K, Sober AJ, Haluska FG. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res. 2005 Feb; 15(1):77-82.spa
dc.relation.referencesThe NCCN Clinical Practice Guidelines in Oncology TM Melanoma (Version 2.2011). Disponible en: www.nccn.org.spa
dc.relation.referencesNguyen y Jaeyoung Yoon. Carcinoma epidermoide. En: Rigel D, Friedman R, Dzubow L, Reintgen D, Bystryn JC and Marks R. Cáncer de piel. Madrid: Elsevier; 2006, p. 133 v.spa
dc.relation.referencesMelanoma. http://www.seom.org/es/informacion-sobre-el-cancer/info-tipos-cancer/melanoma?start=6#sthash.CO8BFszn.dpufspa
dc.relation.referencesCarter R, Marks R, Hill D. Could a national skin cancer primary prevention campaign in Australia be worthwhile?: An economic perspective. Health Promotion International. 1999; 14(1):73-82.spa
dc.relation.referencesGordon LG, Scuffam PA, van der Pols JC, McBride P, Williams GM, Green AC. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings. J Invest Dermatol. 2009; 129(12):2766-71.spa
dc.relation.referencesHirst NG, Gordon LG, Scuffam PA, Green AC. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value Health. 2012; 15(2):261-8.spa
dc.relation.referencesShih ST, Carter R, Sinclair C, Mihalopoulos C, Vos T. Economic evaluation of skin cancer prevention in Australia. Prev Med. 2009; 49(5):449-53.spa
dc.relation.referencesLebwohl M. Actinic keratosis: epidemiology and progression to squamous cell carcinoma. Br J Dermatol. 2003; 149(66):31-3.spa
dc.relation.referencesMancebo SE, Hu JY, Wang SQ. Sunscreens: A Review of Health Benefits, Regulations, and Controversies. Dermatol Clin. 2014; 32(3):427-38.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Instituto Nacional de Cancerología. Anuario Estadístico 2010. Vol. 8. Bogotá: Buenos y Creativos. 2012.spa
dc.relation.referencesMiller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Making. 1994; 14(1):52-8.spa
dc.relation.referencesCriscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans A airs Topical Tretinoin Chemoprevention Trial. Cancer. 2009; 115(11):2523-30.spa
dc.relation.referencesLansbury L, Leonardi J, Perkins W, Goodacre T, Tweed JA, Bath FJ. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev. 2010; (4):CD007869.spa
dc.relation.referencesNCCN. National Comprehensive Cancer Network. Basal Cell and Squamous Cell Skin Cancers. NCCN Guidelines. 2014; 2:1-48. Disponible en: URL: www.nccn.comspa
dc.relation.referencesChren MM, Linos E, Torres JS, Stuart SE, Parvataneni R, Boscardin WJ. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2013; 133(5):1188-96.spa
dc.relation.referencesSmeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004; 364(9447):1766-72.spa
dc.relation.referencesGupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012; 12:CD004415.spa
dc.relation.referencesBriggs AH. Handling uncertainty in cost-e ectiveness models. Pharmacoeconomics. 2000; 17(5):479-500.spa
dc.rightsMaría Lucía Iregui Piñeros, Jaime Ronderos Osorio - 2017spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.juanncorpas.edu.co/index.php/cartacomunitaria/article/view/212spa
dc.subjectMedicinaspa
dc.subjectAprendizajespa
dc.subjectAprendizaje basado en problemasspa
dc.subjectEscuelas médicasspa
dc.subjectDocentesspa
dc.subjectPromoción de la saludspa
dc.subjectNeoplasiasspa
dc.subjectNeoplasias cutáneasspa
dc.titleCáncer de piel: Una realidad cotidianamente ignorada.spa
dc.title.translatedCáncer de piel: Una realidad cotidianamente ignorada.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublicationspa

Archivos

Colecciones

AMD. Carta Comunitaria